Brian Abeysekera
Nessuna posizione attualmente
Profilo
Brian Abeysekera has been Vice President-Marketing of Molecular Insight Pharmaceuticals, Inc. since April 2007.
He has over 20 years of experience in radioisotope and radiopharmaceutical development, including production, radiochemistry, quality control, quality assurance and regulatory affairs activities in the United States and Canada.
Previously, he served as Director of Applied Research and Development MDS Nordion, Inc. Dr. Abeysekera received a PhD in Synthetic Organic Chemistry from the University of British Columbia.
Precedenti posizioni note di Brian Abeysekera
| Società | Posizione | Fine |
|---|---|---|
MDS Nordion, Inc.
 MDS Nordion, Inc. Pharmaceuticals: OtherHealth Technology MDS Nordion, Inc. use to export medical isotopes, radio therapeutics and related technologies. Its products and services were used in hospitals, clinics, large medical supply companies, biotechnology, pharmaceutical companies, food processors and manufacturers. The company was founded in 1946 and was headquartered in Ottawa, Canada. | Direttore Tecnico/Scientifico/R&S | - |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Brian Abeysekera
| University of British Columbia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
MDS Nordion, Inc.
MDS Nordion, Inc. Pharmaceuticals: OtherHealth Technology MDS Nordion, Inc. use to export medical isotopes, radio therapeutics and related technologies. Its products and services were used in hospitals, clinics, large medical supply companies, biotechnology, pharmaceutical companies, food processors and manufacturers. The company was founded in 1946 and was headquartered in Ottawa, Canada. | Health Technology |
- Borsa valori
- Insiders
- Brian Abeysekera
